Major histocompatibility complex class I-restricted antigen processing and presentation.
about
Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expressionImmune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyNoncanonical peptides in complex with MHC class I.MHC-bound antigens and proteomics for novel target discovery.Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib moleculesThe design and implementation of the immune epitope database and analysis resource.Redox-regulated export of the major histocompatibility complex class I-peptide complexes from the endoplasmic reticulumReduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages.Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization.Polymorphisms of transporter associated with antigen processing type 1 (TAP1), proteasome subunit beta type 9 (PSMB9) and their common promoter in African children with different manifestations of malaria.The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins.Role of autophagy in MHC class I-restricted antigen presentation.Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.The turnover kinetics of major histocompatibility complex peptides of human cancer cells.Molecular backgrounds of ERAP1 downregulation in cervical carcinoma.Personalized medicine for HLA-associated drug-hypersensitivity reactions
P2860
Q33222048-3E572EAF-9DD1-4F65-8948-8695F4CA0AB7Q33283524-02376C10-8234-4E5C-8AF8-65E3858EBDE6Q33614398-78528FE2-9380-4348-9397-98C2CCC423B8Q33637584-E9DAAD7E-A981-437F-BFC5-E33451378EEEQ35728590-7CFBCAB8-739F-48D0-952E-E4E3C24E8E0CQ35911151-C8E98868-3E35-4722-9000-538BD0B308ACQ36151380-083AD942-6367-4C01-9E0B-3776CE6C9058Q36228447-81D2AAF6-F715-4012-8CE4-91EB3BFD235BQ36659226-74FA40F3-825C-43B3-A4E3-0C7CCAAFB975Q37262170-C181B23A-5B8F-4F92-B459-0CF7A5FB1DABQ37577694-FCE7C204-02EE-436C-BF00-55197A80036EQ38750956-2D878B69-FB56-48B6-B0A0-BE4896E81917Q39026675-3E9BD0AF-7F1C-4355-AE4A-32CF4F288684Q39304327-12C5D72E-5BBE-43ED-9A76-848F69886093Q41887918-63298B40-9075-4E8F-AA85-0DDB691AEA3BQ47415796-2B63A253-FF4A-4135-B009-2B748A37C5EAQ53360861-1D0867C1-5377-4324-9B32-938437434B05Q53650261-214CB337-BE5A-4E84-9C1C-6FE3E638A8A8Q55437991-23F93078-670A-4A6A-9DC6-D643D395CE0AQ57223243-38DF0282-55D7-4636-A5AB-D3AC6902B29D
P2860
Major histocompatibility complex class I-restricted antigen processing and presentation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Major histocompatibility complex class I-restricted antigen processing and presentation.
@ast
Major histocompatibility complex class I-restricted antigen processing and presentation.
@en
Major histocompatibility complex class I-restricted antigen processing and presentation.
@nl
type
label
Major histocompatibility complex class I-restricted antigen processing and presentation.
@ast
Major histocompatibility complex class I-restricted antigen processing and presentation.
@en
Major histocompatibility complex class I-restricted antigen processing and presentation.
@nl
prefLabel
Major histocompatibility complex class I-restricted antigen processing and presentation.
@ast
Major histocompatibility complex class I-restricted antigen processing and presentation.
@en
Major histocompatibility complex class I-restricted antigen processing and presentation.
@nl
P2860
P1433
P1476
Major histocompatibility complex class I-restricted antigen processing and presentation.
@en
P2093
Van Kaer L
P2860
P356
10.1034/J.1399-0039.2002.600101.X
P577
2002-07-01T00:00:00Z